Latest News Archive

Please select Category, Year, and then Month to display items

Global Citizen - In conversation with Rohitesh Dhawan

23 October 2023 | Story Carmenita Redcliffe-Paul

The University of the Free State (UFS) and the South African Chamber of Commerce United Kingdom (SACC UK) are pleased to invite you to the next conversation of the Global Citizen Series.

SACC UK representative, Director of Mindofafox, futurist, and bestselling author, Chantell Ilbury, will facilitate this thought-provoking and engaging conversation between UFS Vice-Chancellor and Principal, Prof Francis Petersen, and President and Chief Executive of the International Council on Mining and Metals (ICMM), Rohitesh Dhawan.

The discussion will explore the strategic priorities and breakthroughs in the mining and metals industry in relation to critical areas of climate and environmental resilience, social performance, governance, ethics and transparency, and innovation for sustainability.

Dhawan, a Fellow and faculty member of the Africa Leadership Initiative, will reflect on leadership through collaboration to enhance the contribution of mining and metals towards sustainable development, security of minerals within a changing geopolitical environment and the progress that is possible when citizens collectively focus on improving the lives of others and our planet.

Participate in the Global Citizen event in person or online via live stream.

Kindly RSVP on the links below and indicate your preferred method of participation.

Join the Global Citizen in person in London, United Kingdom

Date: Wednesday, 8 November 2023

Time: 17:30-19:30

Venue: SOAS Brunei Gallery – SOAS, University of London, Thornhaugh Street, Russell Sq, London WC1B 5DQ, United Kingdom

RSVP: Friday, 27 October 2023

Enquiries: Adrienne Hall E: adrienne@creative-partnerships.co.uk or T: +44 7469 219157

Light refreshments will be served after the event.

Join the Global Citizen event online

Date: Wednesday, 8 November 2023

SA time 20:00-21:00 SAST

UK time 18:00-19:00 GMT

RSVP here by Friday, 3 November 2023

The live stream link will be shared upon RSVP.

About Rohitesh Dhawan

Rohitesh Dhawan was appointed President and Chief Executive Officer of ICMM in April 2021. He is passionate about the transformative power of mining, particularly in emerging markets where he has spent two-thirds of his life. Dhawan is a Fellow and faculty member of the Africa Leadership Initiative and a Raisina fellow of the Asian Forum on Global Governance. He serves on the advisory boards of the Columbia Centre on Sustainable Investment, Concordia, and Resolve.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept